Product Program year 2025 Source: CMS Open Payments

Brinsupri

Drug Respiratory

NDC 71558-001-30

Open in the dashboard

General payments

$200,444

8,653 payments

Research payments

$0

0 payments

Through program year 2025, $200,444 in general payments and $0 in research payments were reported against Brinsupri (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $200,444 8,653

Breakdown

Who paid General payments · program year 2025
  1. Insmed, Inc. $200,444 8,653 payments
Top recipients General payments · program year 2025
  1. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $6,000 3% · 1 payment
  2. Joseph Khabbaza Pulmonary Disease · Akron, OH $4,596 2% · 14 payments
  3. Robert Jasmer Pulmonary Disease · Burlingame, CA $1,923 <1% · 3 payments
  4. Strong Memorial Hospital Teaching hospital · NY $1,750 <1% · 1 payment
  5. Lahey Clinic Hospital Inc. Teaching hospital · MA $1,500 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $87,366 47% · 2,092 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $18,163 10% · 445 practitioners
  3. Infectious Disease Internal Medicine $14,996 8% · 395 practitioners
  4. Internal Medicine $10,354 6% · 327 practitioners
  5. Critical Care Medicine Internal Medicine $10,018 5% · 287 practitioners

The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $31,197 16% · 737 recipients
  2. Texas $12,752 6% · 339 recipients
  3. Michigan $12,166 6% · 186 recipients
  4. California $12,164 6% · 306 recipients
  5. New York $11,699 6% · 276 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

8,653 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record